IGF1, insulin like growth factor 1, 3479

N. diseases: 1206; N. variants: 36
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0015934
Disease: Fetal Growth Retardation
Fetal Growth Retardation
0.400 GeneticVariation phenotype BEFREE The pathogenic <i>IGF1R</i> mutation in this girl led to intrauterine growth retardation followed by partial postnatal catch-up growth. 30859796 2019
CUI: C0015934
Disease: Fetal Growth Retardation
Fetal Growth Retardation
0.400 Biomarker phenotype BEFREE Early T depressed serum insulin-like growth factor 1 and caused intrauterine growth restriction (IUGR; P < 0.0005). 30095996 2018
CUI: C0015934
Disease: Fetal Growth Retardation
Fetal Growth Retardation
0.400 AlteredExpression phenotype BEFREE In this hypothetical scenario, IUGR-induced deficit of IGF-1 causes "diabetic" aging trajectory associated with various metabolic disorders in adulthood, while fetal macrosomia-induced excessive levels of IGF-1 lead to "cancerous" aging trajectory. 29626501 2018
CUI: C0015934
Disease: Fetal Growth Retardation
Fetal Growth Retardation
0.400 Biomarker phenotype BEFREE The results showed FBG, FINS and HOAM-IR in CUG-FGR group were higher than those in high fat feeding control group (NC+HF), but the content of IGF-1 in blood was lower than that in NC + HF group. 29442728 2018
CUI: C0015934
Disease: Fetal Growth Retardation
Fetal Growth Retardation
0.400 Biomarker phenotype BEFREE IUGR fetuses had low circulating insulin and insulin-like growth factor 1 (IGF1) and high circulating cortisol. 30143557 2018
CUI: C0015934
Disease: Fetal Growth Retardation
Fetal Growth Retardation
0.400 Biomarker phenotype BEFREE We investigated the effects of intra-amniotic IGF1 administration to ovine fetuses with uteroplacental embolisation-induced FGR on phenotypical and physiological characteristics in the 2  weeks after birth. 29235113 2018
CUI: C0015934
Disease: Fetal Growth Retardation
Fetal Growth Retardation
0.400 Biomarker phenotype BEFREE Novel functional role of GH/IGF-I in neonatal lung myofibroblasts and in rat lung growth after intrauterine growth restriction. 30047284 2018
CUI: C0015934
Disease: Fetal Growth Retardation
Fetal Growth Retardation
0.400 Biomarker phenotype BEFREE Intraplacental gene transfer of IGF-1 prevents FGR induced cardiac dysfunction. 28099426 2017
CUI: C0015934
Disease: Fetal Growth Retardation
Fetal Growth Retardation
0.400 Biomarker phenotype BEFREE These results demonstrate that the molecular machinery necessary for transcriptional control of proliferation remains intact in IUGR fetal myoblasts, indicating that in vivo factors such as reduced insulin and IGF1, hypoxia and/or elevated counter-regulatory hormones may be inhibiting muscle growth in IUGR fetuses. 28053000 2017
CUI: C0015934
Disease: Fetal Growth Retardation
Fetal Growth Retardation
0.400 GeneticVariation phenotype BEFREE Finally, IUGR significantly altered the nucleosome-depleted region (NDR) at the in2GHRE of IGF-1 on postnatal day 21, with either complete absence of the NDR or with a shifted NDR exposing only one of two STAT5b DNA binding sites. 26487705 2015
CUI: C0015934
Disease: Fetal Growth Retardation
Fetal Growth Retardation
0.400 ModifyingMutation phenotype RGD Periconceptional alcohol consumption causes fetal growth restriction and increases glycogen accumulation in the late gestation rat placenta. 24239160 2014
CUI: C0015934
Disease: Fetal Growth Retardation
Fetal Growth Retardation
0.400 AlteredExpression phenotype BEFREE Notably, at 28 weeks' gestation there was increased IGF2 (3.9-fold), placental growth hormone (2.7-fold), and IGF BP2 (2.1-fold) expression in maternal blood in women destined to develop FGR at term (P < .05). 23583218 2013
CUI: C0015934
Disease: Fetal Growth Retardation
Fetal Growth Retardation
0.400 Biomarker phenotype BEFREE Heterozygous mutations in the IGF1 receptor (IGF1R) gene lead to partial resistance to IGF1 and contribute to intrauterine growth retardation (IUGR) with postnatal growth failure. 23045302 2013
CUI: C0015934
Disease: Fetal Growth Retardation
Fetal Growth Retardation
0.400 GeneticVariation phenotype BEFREE With the first descriptions of patients born small for gestational age carrying mutations within the insulin-like growth factor type 1 receptor (IGF-1R) gene, genetic defects at the lower end of the GH-IGF-1 axis were identified as a monogenetic cause of intrauterine growth retardation. 23182819 2012
CUI: C0015934
Disease: Fetal Growth Retardation
Fetal Growth Retardation
0.400 GeneticVariation phenotype BEFREE The aim of our study was to determine the ontogeny of key IGF axis genes and other growth regulating imprinted genes in the placenta and to characterize patterns of placental gene expression associated with intrauterine growth restriction (IUGR). 22154689 2012
CUI: C0015934
Disease: Fetal Growth Retardation
Fetal Growth Retardation
0.400 AlteredExpression phenotype BEFREE Gene expression patterns of insulin-like growth factor 1, insulin-like growth factor 2 and insulin-like growth factor binding protein 3 in human placenta from pregnancies with intrauterine growth restriction. 21823995 2011
CUI: C0015934
Disease: Fetal Growth Retardation
Fetal Growth Retardation
0.400 AlteredExpression phenotype BEFREE Decreased placental expression levels of hPGH, IGF-I and IGFBP-1 were demonstrated in pregnancies with FGR. 21212012 2011
CUI: C0015934
Disease: Fetal Growth Retardation
Fetal Growth Retardation
0.400 Biomarker phenotype BEFREE There were significantly lower concentrations of glucose, insulin, IGF-1, and IGF-II in the fetal cord blood of pregnancies with IUGR (p<0.05). 20106611 2010
CUI: C0015934
Disease: Fetal Growth Retardation
Fetal Growth Retardation
0.400 Biomarker phenotype BEFREE Changes in GH/IGF-1 axis in intrauterine growth retardation: consequences of fetal programming? 19623512 2009
CUI: C0015934
Disease: Fetal Growth Retardation
Fetal Growth Retardation
0.400 AlteredExpression phenotype BEFREE Elevated IGF binding protein (IGFBP)-1 expression associated with fetal growth restriction has been documented. 18772238 2009
CUI: C0015934
Disease: Fetal Growth Retardation
Fetal Growth Retardation
0.400 AlteredExpression phenotype LHGDN Low intrauterine IGF-I serum levels may account for thinner and stiffer umbilical arteries in IUGR infants in comparison to AGA infants thereby providing a potential link to arterial hypertension in adulthood. 19070892 2009
CUI: C0015934
Disease: Fetal Growth Retardation
Fetal Growth Retardation
0.400 Biomarker phenotype RGD To investigate the expressions of the insulin receptor (IR), insulin receptor substrate-1 (IRS-1), insulin receptor substrate-2 (IRS-2), phosphatidyl inositol 3-kinase (PI3K) and insulin-like growth factor-1 (IGF-1) of the livers of the male adult rats born with intrauterine growth retardation (IUGR),and to find out the relationship between IUGR and insulin resistance in their adult life. 19088829 2008
CUI: C0015934
Disease: Fetal Growth Retardation
Fetal Growth Retardation
0.400 GeneticVariation phenotype BEFREE IGFs are low in human SGA newborns; however, only a small minority of these infants have mutations of IGF-related molecules, rather, idiopathic or maternal factors are thought to induce FGR in most of these cases. 19202510 2008
CUI: C0015934
Disease: Fetal Growth Retardation
Fetal Growth Retardation
0.400 AlteredExpression phenotype LHGDN There was a significant positive correlation between aIMT and gestational age, whereas a significant negative correlation was determined between aIMT and IGF-I in the IUGR neonates. 17957164 2007
CUI: C0015934
Disease: Fetal Growth Retardation
Fetal Growth Retardation
0.400 AlteredExpression phenotype BEFREE In addition to imprinted genes, the microarray data highlighted non-imprinted genes acting in endocrine signaling (LEP, CRH, HPGD, INHBA), tissue growth (IGF1), immune modulation (INDO, PSG-family genes), oxidative metabolism (GLRX), vascular function (AGTR1, DSCR1) and metabolite transport (SLC-family solute carriers) as differentially expressed in IUGR vs. non-IUGR placentae. 16125225 2006